4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and Ptosis, Eyelid

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with Ptosis, Eyelid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bervoets, K; Brocco, M; Canton, H; Gobert, A; Lejeune, F; Millan, MJ; Peglion, JL; Rivet, JM; Widdowson, P	1

Other Studies

1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and Ptosis, Eyelid

Article	Year
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively. European journal of pharmacology, 1993, Jan-05, Volume: 230, Issue:1 Topics: Animals; Behavior, Animal; Blepharoptosis; Body Temperature; Brain Chemistry; Ligands; Male; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses	1993

Article

Year

S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.

European journal of pharmacology, 1993, Jan-05, Volume: 230, Issue:1

Topics: Animals; Behavior, Animal; Blepharoptosis; Body Temperature; Brain Chemistry; Ligands; Male; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses

1993